poisar

Stocks · News reference

Occidental Petroleum To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Tuesday

BenzingaAvi Kapoor

Analysts cut targets for WING, ELAN, SBAC and RH; raised targets for TRV, OXY and GILD, with ELAN downgraded to Hold.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolStefon Walters

    If I Were Investing My First $1,000 Today, This Is the ETF I'd Buy and Hold for Decades

    The article recommends the Vanguard S&P 500 ETF (VOO) as an ideal first investment for beginners with $1,000. VOO offers diversification across all major U.S. sectors, has a low expense ratio of 0.03%, and has delivered an average annual return of 12.4% since inception. The S&P 500 is presented as a reliable, long-term investment strategy that requires minimal effort and decision-making.

  2. The Motley FoolBen Gran

    Warren Buffett Says Bad News Is an Investor's Best Friend. History Says He's Right.

    Warren Buffett's October 2008 op-ed advocated buying U.S. stocks during market crashes, arguing that bad news presents the best investment opportunities. Historical data supports this thesis, showing that investing during crises like the Great Depression, WWII, and early 1980s inflation led to substantial long-term gains. The article emphasizes that patient investors who buy low-cost index funds during downturns and hold for years can capture significant returns, as America's economy has consistently recovered from major crises.

  3. The Motley FoolWill Healy

    Is Micron Next to Announce a Stock Split?

    While Micron Technology's stock price of around $735 per share might suggest it's a candidate for a stock split—its first since 2000—the article argues it's unlikely to be the next tech stock to split. The company faces historical volatility concerns from the memory chip industry's cyclicality, and with revenue growth expected to slow to 16% by fiscal 2028, the company will likely approach any split decision cautiously.

  4. Globenewswire IncPrecedence Research

    Pharmaceutical Market to Reach USD 3.20 Trillion by 2035 as Obesity and Oncology Drugs Lead Growth and U.S. Pricing Deals and Tariffs Reshape Manufacturing

    The global pharmaceutical market is valued at USD 1.88 trillion in 2026 and is projected to reach USD 3.20 trillion by 2035 at a CAGR of 6.10%. Growth is concentrated in obesity and oncology therapies, with U.S. pricing deals and Section 232 tariffs reshaping manufacturing. North America holds 42% of the market, while companies with strong positions in GLP-1 medicines and cancer therapies are growing significantly faster than the market.